Sotera Health Company revised earnings guidance for the full year 2023. The company expects Net revenues in the range of $1.035 to $1.055 billion, from previous guidance of $1.055 billion to $1.090 billion, representing growth of approximately 3% to 5%, compared to the prior year.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
11.34 USD | +2.67% | +0.41% | -32.72% |
05-02 | Sotera Health Shares Fall After Q1 Results, Outlook Reaffirmed | MT |
05-02 | Transcript : Sotera Health Company, Q1 2024 Earnings Call, May 02, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-32.72% | 3.13B | |
+17.52% | 85.55B | |
-28.32% | 70.07B | |
+6.76% | 28.95B | |
-7.31% | 17.51B | |
+2.14% | 17.39B | |
+2.10% | 15.38B | |
+6.47% | 13.4B | |
+66.01% | 12.93B | |
+6.64% | 12.77B |
- Stock Market
- Equities
- SHC Stock
- News Sotera Health Company
- Sotera Health Company Revises Earnings Guidance for the Full Year 2023